Skip to content
← Non-Small Cell Lung Cancer

HEALTH PROFESSIONAL · SOURCE READING

Conventional radiation therapy

Source: Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Stages IA and IB NSCLC / Treatment Options for Stages IA and IB NSCLC / Radiation therapy

Historically, conventional primary radiation therapy consisted of approximately 60 Gy to 70 Gy delivered with megavoltage equipment to the midplane of the known tumor volume using conventional fractionation (1.8–2.0 Gy per day).

Improvements in radiation techniques include planning techniques to account for tumor motion, more conformal planning techniques (e.g., 3-D conformal radiation therapy and intensity-modulated radiation therapy), and image guidance during treatment. Modern approaches to delivery of external-beam radiation therapy (EBRT) include hypofractionated radiation therapy and stereotactic body radiation therapy (SBRT). However, there are limited reliable data from comparative trials to determine which approaches yield superior outcomes.[18,19]

Source links and citations

Evidence (conventional radiation therapy):

In the largest retrospective conventional radiation therapy series, patients with inoperable disease were treated with definitive radiation therapy.[21-23]

Source links and citations

In the largest retrospective conventional radiation therapy series, patients with inoperable disease were treated with definitive radiation therapy.[21-23]

Patients achieved 5-year survival rates of 10% to 30%.[21-23]

Source links and citations

In the largest retrospective conventional radiation therapy series, patients with inoperable disease were treated with definitive radiation therapy.[21-23]

Several series demonstrated that patients with T1, N0 tumors had better outcomes, and 5-year survival rates of 30% to 60% were found in this subgroup.[21,22,24]

Source links and citations

In the largest retrospective conventional radiation therapy series, patients with inoperable disease were treated with definitive radiation therapy.[21-23]

However, local-only failure occurs in as many as 50% of patients treated with conventional radiation therapy to doses in the range of 60 Gy to 65 Gy.[25,26]

Source links and citations

A single report of patients older than 70 years who had resectable lesions smaller than 4 cm but who had medically inoperable disease or who refused surgery reported the following:[24]

Source links and citations

A single report of patients older than 70 years who had resectable lesions smaller than 4 cm but who had medically inoperable disease or who refused surgery reported the following:[24]

Survival at 5 years after radiation therapy with curative intent was comparable with a historical control group of patients of similar age who were resected with curative intent.

A small case series using matched controls reported the following:[4]

Source links and citations

A small case series using matched controls reported the following:[4]

The addition of endobronchial brachytherapy improved local disease control compared with EBRT.[4][Level of evidence C2]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice